{"screen_name":{"0":"NEJM","1":"NEJM","2":"NEJM","3":"NEJM","4":"NEJM","5":"NEJM","6":"NEJM"},"tweet_id":{"0":1326974862108340225,"1":1326961345024188416,"2":1326947870906306560,"3":1326932779062317056,"4":1326902575543672832,"5":1326887480889470977,"6":1326872372712890369},"is_retweet":{"0":true,"1":true,"2":false,"3":false,"4":false,"5":false,"6":false},"text":{"0":"There has been promising #COVID19 vaccine results and progress on #HIV prevention \u2014 all in one great day. @PaulSaxMD discusses the latest news in HIV and ID Observations. https:\/\/t.co\/VJOjKnfbjI https:\/\/t.co\/G68GLFIni9","1":"The FDA has issued an emergency use authorization for balmanivimab, a monoclonal antibody, for mild-to-moderate #COVID19. Elsewhere, a study finds that reducing maximum occupancy at certain public venues will do more to limit transmission than reducing mobility overall.","2":"This letter describes an immunocompromised patient who had persistent infection with #SARSCoV2 over a period of months, despite several courses of remdesivir. Phylogenetic analysis showed accelerated viral evolution. #COVID19","3":"Select Villages in Niger offered azithromycin or placebo to children 1 to 59 months of age every 6 months to 4 years. Stool samples collected showed the antibiotic was more common among children living in villages that received azithromycin over those who received placebo.","4":"This post marketing surveillance study of intussusception risk among infants in India who received the Indian-made oral rotavirus vaccine (Rotavac) did not show an increased risk of intussusception in any risk window.","5":"Holly Taylor discusses the ethical issues involved in conducting Covid-19 vaccine research in correctional facilities. #COVID19 #SARSCoV2","6":"In this audio interview conducted on November 9, the editors are joined by Dr. Janet Woodcock of Operation Warp Speed to discuss the pace of discovery in the U.S. response to #COVID19. #SARSCoV2"},"user_verified":{"0":true,"1":true,"2":true,"3":true,"4":true,"5":true,"6":true},"created_at":{"0":"2020-11-12 19:47:15","1":"2020-11-12 18:53:33","2":"2020-11-12 18:00:00","3":"2020-11-12 17:00:02","4":"2020-11-12 15:00:01","5":"2020-11-12 14:00:02","6":"2020-11-12 13:00:00"},"retweet_count":{"0":12,"1":21,"2":149,"3":6,"4":7,"5":4,"6":8},"favorite_count":{"0":0,"1":0,"2":365,"3":56,"4":48,"5":20,"6":19},"user_location":{"0":"Boston, MA","1":"Boston, MA","2":"Boston, MA","3":"Boston, MA","4":"Boston, MA","5":"Boston, MA","6":"Boston, MA"},"user_url":{"0":"http:\/\/t.co\/MskhpINH4c","1":"http:\/\/t.co\/MskhpINH4c","2":"http:\/\/t.co\/MskhpINH4c","3":"http:\/\/t.co\/MskhpINH4c","4":"http:\/\/t.co\/MskhpINH4c","5":"http:\/\/t.co\/MskhpINH4c","6":"http:\/\/t.co\/MskhpINH4c"},"entities":{"0":{"hashtags":[{"text":"COVID19","indices":[37,45]},{"text":"HIV","indices":[78,82]}],"symbols":[],"user_mentions":[{"screen_name":"JWatch","name":"NEJM Journal Watch","id":25952049,"id_str":"25952049","indices":[3,10]},{"screen_name":"PaulSaxMD","name":"Paul Sax","id":30761456,"id_str":"30761456","indices":[118,128]}],"urls":[]},"1":{"hashtags":[],"symbols":[],"user_mentions":[{"screen_name":"Physns1stWatch","name":"PhysiciansFirstWatch","id":130593087,"id_str":"130593087","indices":[3,18]}],"urls":[]},"2":{"hashtags":[{"text":"SARSCoV2","indices":[85,94]},{"text":"COVID19","indices":[217,225]}],"symbols":[],"user_mentions":[],"urls":[]},"3":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]},"4":{"hashtags":[],"symbols":[],"user_mentions":[],"urls":[]},"5":{"hashtags":[{"text":"COVID19","indices":[119,127]},{"text":"SARSCoV2","indices":[128,137]}],"symbols":[],"user_mentions":[],"urls":[]},"6":{"hashtags":[{"text":"COVID19","indices":[175,183]},{"text":"SARSCoV2","indices":[185,194]}],"symbols":[],"user_mentions":[],"urls":[]}}}